HOME
ABOUT
PROJECTS
NEWS
OUTPUT
POSITIONS
- Jobs
- Vacancies
LINKS
TRAINING & TEACHING WEBSITES & APP
CONTACT

✕

Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis

Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis

Read the article on our ERC grant “Clostridium-based Immunotherapy” which has been published on the CORDIS website in six languages at:

https://lnkd.in/g5AQSvR

CONTACT INFO

Phone

+31 (0)43 3883549

E-mail

info@precisionmedicinemaastricht.eu

OUR OFFICE

Universiteitssingel 40,
room 4.535 | 4th floor,
6229 ER Maastricht

© 2019 Precision Medicine. All Rights Reserved. Website by WEBWEAVER.be

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok